Sankey It
Loading...
Eli Lilly and Company Q2 FY2025 income statement | Sankey It
Sankey It · LLY
Eli Lilly and Company Q2 FY2025 income statement
USD · quarter ended 2025-06-30
Q2 FY2026
Q1 FY2026
Q4 FY2025
Q3 FY2025
Q2 FY2025
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Eli Lilly and Company Q2 FY2025 income statement
Flow diagram with 8 nodes and 7 flows for Eli Lilly and Company Q2 FY2025 income statement. Values: Revenue US$15.6B, Cost of Revenue US$2.4B, Gross Profit US$13.1B, Operating Expenses US$6B, Operating Income US$7.1B, Other Expense US$349.8M, Tax US$1.1B, Net Income US$5.7B.
Revenue
US$15.6B
Cost of Revenue
(US$2.4B)
16% of revenue
Gross Profit
US$13.1B
84% margin
Operating Expenses
(US$6B)
38% of revenue
Operating Income
US$7.1B
46% margin
Other Expense
(US$349.8M)
2% of revenue
Tax
(US$1.1B)
7% of revenue
Net Income
US$5.7B
36% margin
Net / profit
Tax / cost
Copy link
Share on X
Open full screen